News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15 Results
Section
Business (5)
Deals (2)
Drug Development (1)
News (9)
Policy (1)
Tag
Alliances (5)
Clinical research (1)
Events (1)
Mergers & acquisitions (2)
Phase I (1)
Regulatory (1)
Date
2019 (3)
2018 (5)
2016 (1)
2013 (1)
2012 (2)
2011 (1)
2010 (1)
15 Results for "serametrix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Caprion Biosciences expands its global biomarker and immune monitoring franchise by acquiring Serametrix Corporation
Caprion Biosciences announced that the company acquired Serametrix Corporation, a specialized provider of immune monitoring services headquartered in Carlsbad, California.
April 30, 2019
·
3 min read
Biotech Beach
ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study
Prostate cancer study with Serametrix in which data from a previous collaboration between Serametrix and Memorial Sloan Kettering Cancer Center (MSK) was re-evaluated using ITUS technology.
March 27, 2018
·
5 min read
Business
ITUS Corporation Forms Alliance with Serametrix Corporation
Serametrix flow cytometry and related data analysis services are already widely used in immunotherapy drug trials.
March 5, 2018
·
3 min read
Drug Development
Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs
First Patient Enrolled in IPI-549 Plus OPDIVO® MDSC-High Cohort in Infinity Pharmaceuticals Ongoing IPI-549-01 Phase 1/1b Clinical Trial
May 22, 2018
·
6 min read
Policy
Serametrix Gains CLIA Certification For MDSC-Based Blood Test For Predicting Response To Immunotherapy In Cancer Patients
September 29, 2016
·
2 min read
Biotech Beach
MDSC-based Blood Test For Predicting Response To Cancer Therapy Commercialized By Serametrix
November 19, 2013
·
1 min read
Business
Penn State Hershey and Serametrix to Seek Companion Diagnostic for Immunotherapy in Pediatric Cancers
April 16, 2012
·
1 min read
Business
OncoSec Medical Inc. and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
November 16, 2011
·
4 min read
Biotech Beach
Serametrix Launches Test for Measuring Serum Antibodies to Leading Cancer Antigen NY-ESO-1
April 15, 2010
·
1 min read
Business
Serametrix Partners with the Ludwig Institute For Cancer Research (LICR) to Develop and Commercialize Serum-Based Diagnostics
October 14, 2009
·
2 min read
1 of 2
Next
